Additional prospective and large studies are required to verify our results and evaluate if molecular imaging can be useful for predicting the status of PD-L1 in gastric cancers, as well as for assisting the treatment decision making on when to employ anti-PD-L1 blocker therapies. The gene discussed is CD274; the disease is gastric cancer.